Country-wise Listing - Libya

To view the articles from different countries, Please click on the country name on left side countries menu.
S.NO Title & Authors Name page
Multidrug resistant tuberculosis (MDR-TB): A lethal risk in Benghazi City, Libya
Mohamed F. Abbar; Yousef M. Sherif; Heba J. Majbri; Makarim Elfadil M. Osman and Emadeldin Hassan E. Konozy
 Abstract                  View                 Download                 XML
Anti-tuberculosis (TB) drug resistance is a major public health problem that threatens TB treatment progress made in the inhabitants of countries in Europe, Asia, Africa, and the America. A retrospective study for the pulmonary TB cases admitted to Quefia Chest Hospital Benghazi, Libya, from 1/1/2009 till 1/6/2010 showed that 4 cases out of 430 TB patients were positive for sensitivity culture and didn\'t respond to the first line anti-TB therapy and therefore were diagnosed as Multidrug Resistant Tuberculosis (MDR-TB). One of these patients was Libyan while others were aliens. The 2nd line anti-TB drugs were given in the form of Amikacin injection, cycloserine, moxifloxacin and pyrazinamide for the first 6 months followed by 18 months therapy with moxifloxacin, cycloserine and pyrazinamide. Follow-up with the patients exhibited clinical-radiological and microbiological improvement.